Previsioni di mercato per il trattamento dell\'ematuria in Medio Oriente e Africa fino al 2028 - Impatto del COVID-19 e analisi regionale per trattamento (farmaci, terapie e altri), indicazione (infezioni del tratto urinario, calcoli renali, uretrite, cancro del sangue, calcoli alla vescica, cancro alla prostata, cistite) , traumi, esercizio fisico intenso, malattia renale policistica, endometriosi e mestruazioni), tipo (ematuria macroscopica, ematuria microscopica, ematuria idiopatica ed ematuria da jogging), utente finale (ospedali, cliniche e centri chirurgici ambulatoriali e altri)
Introduzione al mercato
L\'ematuria è una condizione medica in cui si riscontra la presenza di sangue nelle urine . Generalmente, l\'urina non contiene globuli rossi e quindi ciò può causare problemi seri che possono anche causare calcoli renali, infezioni del tratto urinario e altre malattie ereditarie.
Inoltre, l\'ematuria ad alta prevalenza Si prevede che le indicazioni associate rafforzeranno la crescita del mercato durante il periodo di previsione. Tuttavia, i casi non diagnosticati di indicazioni associate limitano la crescita del Medio Oriente e del Medio Oriente. Mercato africano del trattamento dell\'ematuria.
Nella regione MEA, il numero di pazienti ricoverati in unità di terapia intensiva (ICU) è in aumento, così come il numero di farmaci prescritti, creando molti problemi diagnostici e problemi terapeutici per i sistemi sanitari già sovraccarichi. I sintomi del COVID-19 si riscontrano principalmente nel sistema polmonare, ma viene prestata particolare attenzione alle manifestazioni e/o alle conseguenze urogenitali. Il rischio di infezioni gravi è maggiore nei pazienti anziani affetti da insufficienza renale cronica e l’AKI è collegato a un alto tasso di mortalità. Pertanto, era necessario monitorare la funzione renale dei pazienti con COVID-19 grave e la CRRT per proteggere la funzione renale e l’eliminazione delle citochine nei pazienti critici era fondamentale per migliorare il recupero. L’infezione da COVID-19, invece, sembra avere ramificazioni a livello del tratto urogenitale. Nel trattamento del COVID-19, è necessario prendere in considerazione gli organi urogenitali.
Panoramica e dinamiche del mercato
Il Medio Oriente e l\'Europa Si prevede che il mercato del trattamento dell’ematuria in Africa raggiungerà i 46,8 milioni di dollari entro il 2028, rispetto ai 42,0 milioni di dollari del 2021; si prevede che crescerà a un CAGR dell\'1,5% dal 2021 al 2028. La malattia renale cronica (IRC) è una condizione comune e pericolosa per la vita che colpisce una popolazione più ampia. Esistono vari tipi di insufficienza renale cronica, come calcoli renali, glomerulonefrite, malattia renale policistica e infezioni del tratto urinario. L’insufficienza renale cronica è una delle cause principali della prevalenza dell’ematuria. Inoltre, la prevalenza delle IVU tra le donne di età superiore ai 65 anni è di circa il 20% rispetto alla popolazione complessiva, che è di circa l’11%. Attualmente, il Medio Oriente e il Medio Oriente Il mercato africano del trattamento dell\'ematuria sta guadagnando terreno in modo significativo grazie alla crescente prevalenza di indicazioni associate.
Segmenti chiave del mercato
In termini di tipologia, il segmento dell\'ematuria macroscopica rappresentava la quota maggiore del Medio Oriente e dell\'Europa. Mercato del trattamento dell\'ematuria in Africa nel 2020. In termini di trattamento, il segmento dei farmaci rappresentava la quota maggiore del Medio Oriente e del Medio Oriente. Mercato del trattamento dell\'ematuria in Africa nel 2020. In termini di indicazione, il segmento delle infezioni del tratto urinario rappresentava la quota maggiore del Medio Oriente e del Medio Oriente. Mercato del trattamento dell\'ematuria in Africa nel 2020. In termini di utenti finali, il segmento degli ospedali rappresentava la quota maggiore del Medio Oriente e dell\'Europa. Mercato del trattamento dell\'ematuria in Africa nel 2020.
Principali fonti e aziende elencate
Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato del trattamento dell\'ematuria in Medio Oriente e in Medio Oriente. Africa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti del governo nazionale e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd e Boehringer Ingelheim International GmbH.
Rapporto sui motivi per acquistare
- Per comprendere il Medio Oriente e l\'Europa. Panorama del mercato del trattamento dell\'ematuria in Africa e identificare i segmenti di mercato che potrebbero garantire un forte rendimento
- Comprendere il panorama del mercato in continua evoluzione e rimanere al passo con la concorrenza
- Per pianificare in modo efficiente fusioni, acquisizioni e accordi di partnership in Medio Oriente e in Medio Oriente; Mercato del trattamento dell\'ematuria in Africa identificando i segmenti con le vendite probabili più promettenti
- Prendere decisioni aziendali consapevoli partendo da un\'analisi percettiva e completa delle prestazioni di mercato dei vari segmenti
- Per ottenere previsioni sulle entrate del mercato del Medio Oriente e del Medio Oriente Mercato del trattamento dell\'ematuria in Africa basato su vari segmenti per il periodo 2021-2028
MEDIO ORIENTE e Occidente. SEGMENTAZIONE DEL MERCATO DEL TRATTAMENTO DELL\'EMATURIA IN AFRICA
Per Trattamento
- Farmaci
- Terapie
- Altri
Per indicazione
- Infezioni del tratto urinario
- Calcoli renali
- Uretrite
- Cancro del sangue
- Calcoli alla vescica
- Cancro alla prostata
- Cistite
- Trauma
- Vigoroso Esercizio fisico
- Malattia renale policistica
- Endometriosi
- Mestruazioni
Per Tipo
- Ematuria macroscopica
- Ematuria microscopica
- Ematuria idiopatica
- Ematuria del pareggiatore
Per utente finale
- Ospedali
- Cliniche
- Centri chirurgici ambulatoriali (ASC)
- Altro
Per Paese
- Medio Oriente e amp; Africa
- Emirati Arabi Uniti
- Arabia Saudita
- Sudafrica
- Resto del Medio Oriente e del Medio Oriente Africa
Società menzionate
< ul>TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Hematuria Treatment Market – By Treatment
1.3.2 Middle East & Africa Hematuria Treatment Market – By Indication
1.3.3 Middle East & Africa Hematuria Treatment Market – By Type
1.3.4 Middle East & Africa Hematuria Treatment Market – By End User
1.3.5 Middle East & Africa Hematuria Treatment Market – By Country
2. Middle East & Africa Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Middle East & Africa Analysis
6.1 Middle East & Africa Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Middle East & Africa Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Middle East & Africa Hematuria Treatment Market – Geographic Analysis
11.1 Middle East & Africa: Hematuria Treatment Market
11.1.1 Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.2 Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.3 Middle East & Africa: Hematuria Treatment Market, by Indication - Revenue and Forecast to 2028 (USD Million)
11.1.4 Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.5 Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6 Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
11.1.6.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.1.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.1.2 Saudi Arabia: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.3 Saudi Arabia: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.4 Saudi Arabia: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.5 Saudi Arabia: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.2 South Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.1 South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.2.2 South Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.3 South Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.4 South Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.5 South Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.3 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.3.1 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.3.2 UAE: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.3.3 UAE: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.3.4 UAE: Hematuria Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.6.3.5 UAE: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.4 Rest of Middle East & Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.1 Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.4.2 Rest of Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.3 Rest of Middle East & Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.4 Rest of Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.5 Rest of Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 4. Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. UAE Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. UAE Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. UAE Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 16. UAE Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
Table 23. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Middle East & Africa Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. UAE to Show Significant Growth During Forecast Period
Figure 5. Middle East & Africa Hematuria Treatment Market, Industry Landscape
Figure 6. Middle East & Africa PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Middle East & Africa Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Middle East & Africa Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Middle East & Africa: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. Middle East & Africa Hematuria Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 38. Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
Figure 39. Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 40. South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 41. UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 42. Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 43. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 44. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.